TR200904159A1 - Değiştirilmiş salım sağlayan emoksipin formülasyonları. - Google Patents

Değiştirilmiş salım sağlayan emoksipin formülasyonları.

Info

Publication number
TR200904159A1
TR200904159A1 TR2009/04159A TR200904159A TR200904159A1 TR 200904159 A1 TR200904159 A1 TR 200904159A1 TR 2009/04159 A TR2009/04159 A TR 2009/04159A TR 200904159 A TR200904159 A TR 200904159A TR 200904159 A1 TR200904159 A1 TR 200904159A1
Authority
TR
Turkey
Prior art keywords
emoxipine
modified release
formulations
pharmaceutically acceptable
release
Prior art date
Application number
TR2009/04159A
Other languages
English (en)
Inventor
Toksöz Ahmet
Türkyilmaz Ali̇
Ümi̇t Çi̇fter Musa
Original Assignee
Sanovel İlaç San. Ve Ti̇c. A.Ş.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel İlaç San. Ve Ti̇c. A.Ş. filed Critical Sanovel İlaç San. Ve Ti̇c. A.Ş.
Priority to TR2009/04159A priority Critical patent/TR200904159A1/tr
Priority to EP10160217A priority patent/EP2241310A3/en
Publication of TR200904159A1 publication Critical patent/TR200904159A1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/288—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş, değiştirilmiş salım sağlayan farmasötik formülasyonlarla ilgili olup, emoksipin ya da onun farmasötik olarak kabul edilebilir bir tuzunu ve salım kontrol eden bir polimer ile farmasötik olarak kabul edilebilir en az bir yardımcı madde içerir.
TR2009/04159A 2009-04-17 2009-05-28 Değiştirilmiş salım sağlayan emoksipin formülasyonları. TR200904159A1 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2009/04159A TR200904159A1 (tr) 2009-04-17 2009-05-28 Değiştirilmiş salım sağlayan emoksipin formülasyonları.
EP10160217A EP2241310A3 (en) 2009-04-17 2010-04-16 Modified release formulations of emoxypine

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR200903013 2009-04-17
TR2009/04159A TR200904159A1 (tr) 2009-04-17 2009-05-28 Değiştirilmiş salım sağlayan emoksipin formülasyonları.

Publications (1)

Publication Number Publication Date
TR200904159A1 true TR200904159A1 (tr) 2010-11-22

Family

ID=42136009

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2009/04159A TR200904159A1 (tr) 2009-04-17 2009-05-28 Değiştirilmiş salım sağlayan emoksipin formülasyonları.

Country Status (2)

Country Link
EP (1) EP2241310A3 (tr)
TR (1) TR200904159A1 (tr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200903548A1 (tr) * 2009-05-06 2010-11-22 Sanovel İlaç San. Ve Ti̇c. A.Ş. Oral yolla dağılan emoksipin bileşimleri
RU2504376C1 (ru) * 2012-05-04 2014-01-20 Галина Викторовна Сукоян Высокостабильный фармацевтический состав на основе лиофилизата производных 3-оксипиридинов, или метилпиридинов, или их фармацевтически приемлемых солей
RU2540070C1 (ru) * 2013-12-05 2015-01-27 Общество с ограниченной ответственностью "Фармамед" Дихлорацетат 2-этил-6-метил-3-гидроксипиридина, его стабильная кристаллическая форма и способ ее получения
RU2547728C1 (ru) * 2014-02-26 2015-04-10 Владимир Викторович Яснецов Нейротропное средство, обладающее противогипоксической, нейропротекторной, антиамнестической и вестибулопротекторной активностью
RU2614737C1 (ru) * 2016-04-12 2017-03-28 Общество с ограниченной ответственностью "Нормофарм" Способ улучшения памяти
RU2674286C1 (ru) * 2018-03-20 2018-12-07 Исмагилов Искандар Халиуллович Средство для лечения заболевания, обусловленного нарушением окислительного стресса
RU2712445C1 (ru) * 2019-06-04 2020-01-29 Закрытое акционерное общество "ОБНИНСКАЯ ХИМИКО-ФАРМАЦЕВТИЧЕСКАЯ КОМПАНИЯ" Способ получения препарата антиоксидантного действия в форме таблетки с пролонгированным эффектом
RU2749718C1 (ru) * 2020-06-11 2021-06-16 Закрытое акционерное общество "ОБНИНСКАЯ ХИМИКО-ФАРМАЦЕВТИЧЕСКАЯ КОМПАНИЯ" Способ получения препарата антиоксидантного действия в форме таблетки
US20230052453A1 (en) * 2021-08-05 2023-02-16 Moxy Distribution, Inc. Compositions and methods for relieving effects of alcohol consumption

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996002238A1 (fr) * 1994-07-15 1996-02-01 Aktsionernoe Obschestvo Zakrytogo Tipa 'olvik' Agent neurotrope et sedatif et son procede d'obtention
RU2145855C1 (ru) * 1999-05-26 2000-02-27 Смирнов Леонид Дмитриевич Анксиолитическое, противоалкогольное, церебропротекторное лекарственное средство
RU2293557C2 (ru) * 2005-05-05 2007-02-20 Глущенко Оксана Ивановна Средство для местного использования при лечении заболевания кожи и слизистых

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH658595A5 (de) 1983-08-17 1986-11-28 Inst Khim Fiz An Sssr Retinoprotektor zur behandlung von augenerkrankungen.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996002238A1 (fr) * 1994-07-15 1996-02-01 Aktsionernoe Obschestvo Zakrytogo Tipa 'olvik' Agent neurotrope et sedatif et son procede d'obtention
RU2145855C1 (ru) * 1999-05-26 2000-02-27 Смирнов Леонид Дмитриевич Анксиолитическое, противоалкогольное, церебропротекторное лекарственное средство
RU2293557C2 (ru) * 2005-05-05 2007-02-20 Глущенко Оксана Ивановна Средство для местного использования при лечении заболевания кожи и слизистых

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 1996, SMIRNOV, LEONID DMITRIEVICH ET AL: "Nootropic and tranquilizer preparation containing mexidol", XP002550091, retrieved from STN Database accession no. 124:298962 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 2007, "Agent for topical use in treatment of skin and mucosa diseases", XP002550090, retrieved from STN Database accession no. 146:236142 *

Also Published As

Publication number Publication date
EP2241310A3 (en) 2011-12-21
EP2241310A2 (en) 2010-10-20

Similar Documents

Publication Publication Date Title
TR200904159A1 (tr) Değiştirilmiş salım sağlayan emoksipin formülasyonları.
BRPI0910503A2 (pt) compostos, composições farmacêuticas e respectivos usos.
BRPI0918652A2 (pt) Composições farmacêuticas e métodos de libração relacionadas.
CY1119798T1 (el) Μορφη iv υδροχλωρικης ιβαμπραδινης
UY31886A (es) Uso de dronedarona para la preparación de un medicamento para uso en la prevención de la fibrilación auricular permanente
EA201200617A1 (ru) Полимеры на основе циклодекстрина для доставки лекарственных средств
EA201201263A1 (ru) Фармацевтическая композиция, содержащая этексилат дабигатрана
WO2011057262A3 (en) Treatment of infections with tp receptor antagonists
CL2015003580A1 (es) Conjugados de suministro de polinucleotidos in vivo que tienen acoplamientos sensibles a enzima.
CY1115556T1 (el) Φαρμακευτικη συνθεση για χορηγηση απο το στομα η οποια περιλαμβανει ετεξιλικη δαβιγατρανη
BR112012003800A2 (pt) composição, peptídeo, e formulação farmacêutica.
WO2011101863A3 (en) Extended release pharmaceutical compositions of lacosamide
NI201100227A (es) Composiciones de dosis fija farmacéuticas sólidas que comprenden irbesartán y amlodipina, su preparación y su aplicación terapéutica.
DK201270677A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
BRPI0907228A2 (pt) Compostos de tienopiridazina, suas preparações, composições farmacêuticas e usos
WO2011069076A3 (en) Sustained release donepezil formulations
EA200900958A1 (ru) Препарат невирапина пролонгированного высвобождения
BR112012024428A2 (pt) composição farmacêutica de dissolução rápida
WO2011014003A3 (en) (+)-3-hydroxymorphinan derivatives as neuroprotectants
BRPI0821565A2 (pt) Ingrediente farmacêutico ativo sobre um suporte sólido, amorfo e com uma solubilidade aperfeiçoada
MX2011006721A (es) Formulacion farmaceutica de fenofibrato nanonizado.
WO2010079433A3 (en) Pharmaceutical composition comprising melogliptin
TR201803451T4 (tr) Olmesartan formülasyonlari.
TR201108071A2 (tr) Değiştirilmiş salım sağlayan emoksipin formülasyonları.
TR201108075A2 (tr) Değiştirilmiş salım sağlayan emoksipin formülasyonları.